Jan Åke Lindberg

Title: Jan Åke Lindberg: Innovator in Pharmaceutical Compounds

Introduction

Jan Åke Lindberg is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work focuses on improving treatments for various diseases, showcasing his dedication to advancing medical science.

Latest Patents

Jan Åke Lindberg holds a patent for "Amido heteroaromatic compounds." This patent relates to compounds of Formula (I) and includes pharmaceutically acceptable salts thereof. It also covers processes and intermediates used for their preparation, as well as pharmaceutical compositions containing these compounds. The compounds are particularly relevant for the treatment of diseases such as liver disease. He has 1 patent to his name.

Career Highlights

Lindberg is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on innovative solutions that address critical health challenges. His expertise in pharmaceutical chemistry has been instrumental in the development of new therapeutic agents.

Collaborations

Throughout his career, Jan Åke Lindberg has collaborated with talented professionals, including Daniel Tor Pettersen and Stéphanie Marcelle Gueret. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the innovation process.

Conclusion

Jan Åke Lindberg's contributions to pharmaceutical innovation exemplify the impact of dedicated inventors in the medical field. His work continues to influence the development of effective treatments for serious health conditions.